Cross-protection provided by live Shigella mutants lacking major antigens

Int J Med Microbiol. 2013 May;303(4):167-75. doi: 10.1016/j.ijmm.2013.02.017. Epub 2013 Mar 16.

Abstract

The immune response elicited by Shigella infections is dominated by serotype-specific antibodies recognizing the LPS O-antigens. Although a marked antibody response to invasion plasmid antigens (Ipa-s) shared by all virulent strains is also induced, the varying level of immunity elicited by natural infections is serotype-restricted. Previous vaccines have tried to mimic and achieve this serotype-specific, infection-induced immunity. As, however, the four Shigella species can express 50 different types of O-antigens, current approaches with the aim to induce a broad coverage use a mixture of the most common O-antigens combined in single vaccines. In the current study we present data on an alternative approach to generate immunity protective against multiple serotypes. Mutants lacking both major immune-determinant structures (i.e. the Ipa and O-antigens) were not only highly attenuated, but, unlike their avirulent counterparts still expressing these antigens, elicited a protective immune response to heterologous serotypes in a murine model. Evidence is provided that protection was mediated by the enhanced immunogenic potential of minor conserved antigens. Furthermore, the rough, non-invasive double mutants triggered an immune response different from that induced by the smooth, invasive strains regarding the isotype of antibodies generated. These non-invasive, rough mutants may represent promising candidates for further development into live vaccines for the prophylaxis of bacillary dysentery in areas with multiple endemic serotypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Bacterial / genetics
  • Antigens, Bacterial / immunology*
  • Cross Protection*
  • Disease Models, Animal
  • Dysentery, Bacillary / immunology
  • Dysentery, Bacillary / prevention & control*
  • Female
  • Gene Deletion
  • Mice
  • Mice, Inbred BALB C
  • Mutation*
  • Shigella / genetics
  • Shigella / immunology*
  • Shigella Vaccines / administration & dosage
  • Shigella Vaccines / genetics
  • Shigella Vaccines / immunology*
  • Vaccines, Attenuated / administration & dosage
  • Vaccines, Attenuated / genetics
  • Vaccines, Attenuated / immunology

Substances

  • Antigens, Bacterial
  • Shigella Vaccines
  • Vaccines, Attenuated